Hudson Bay Capital Management LP

Position in DNLI — Denali Therapeutics Inc.

CIK 1393825 STAMFORD, CT

Position in DNLI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,343,600

-$3,306,512 QoQ

Shares Held

130,000

-62.5% QoQ

Ownership

0.081%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#78

of 290 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Hudson Bay Capital Management LP holds $565,820,903 across 77 Biotechnology names. DNLI ranks #29 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	390,440	$193,943,261
2	BMRN	Biomarin Pharmaceutical Inc	825,002	$47,206,614
3	ALNY	Alnylam Pharmaceuticals, Inc.	148,720	$44,769,181
4	BNTX	BioNTech SE	260,000	$24,193,000
5	IMCR	Immunocore Holdings plc	590,000	$18,732,500
6	TECH	BIO-TECHNE Corp	200,000	$14,130,000
7	VIR	Vir Biotechnology, Inc.	1,364,000	$13,899,160
8	PTCT	Ptc Therapeutics, Inc.	159,778	$13,033,091

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,343,600	130,000	-62.5%	Shares	Sole	2026-08-14
2026-03-31	$6,650,112	346,360	-23.0%	Shares	Defined	2026-05-13
2025-12-31	$7,429,500	450,000	+47.5%	Shares	Sole	2026-02-13
2025-09-30	$4,428,600	305,000	+5.2%	Shares	Sole	2025-12-15
2025-06-30	$4,057,100	290,000	+16.0%	Shares	Sole	2025-08-18
2025-03-31	$3,398,750	250,000	+170.3%	Shares	Sole	2025-05-14
2024-12-31	$1,885,150	92,500	+168.1%	Shares	Sole	2025-02-14
2024-09-30	$1,004,985	34,500	-80.3%	Shares	Sole	2024-11-13
2024-06-30	$4,063,500	175,000	-20.5%	Shares	Sole	2024-08-14
2024-03-31	$4,514,400	220,000	+25.7%	Shares	Sole	2024-05-15
2023-12-31	$3,755,500	175,000	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.